Fondren Management’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-46,000
| Closed | -$253K | – | 54 |
|
|
2020
Q1 | $253K | Sell |
46,000
-141,720
| -75% | -$779K | 0.64% | 41 |
|
|
2019
Q4 | $970K | Buy |
187,720
+43,720
| +30% | +$226K | 0.99% | 27 |
|
|
2019
Q3 | $871K | Buy |
144,000
+68,000
| +89% | +$411K | 0.72% | 40 |
|
|
2019
Q2 | $627K | Buy |
76,000
+2,524
| +3% | +$20.8K | 0.6% | 44 |
|
|
2019
Q1 | $1.05M | Buy |
73,476
+6,116
| +9% | +$87.2K | 0.83% | 30 |
|
|
2018
Q4 | $771K | Buy |
67,360
+38,360
| +132% | +$439K | 1.01% | 26 |
|
|
2018
Q3 | $580K | Buy |
29,000
+2,000
| +7% | +$40K | 0.52% | 40 |
|
|
2018
Q2 | $675K | Buy |
27,000
+7,000
| +35% | +$175K | 0.52% | 51 |
|
|
2018
Q1 | $515K | Hold |
20,000
| – | – | 0.65% | 30 |
|
|
2017
Q4 | $510K | Buy |
+20,000
| New | +$510K | 0.36% | 38 |
|
|
2017
Q3 | – | Sell |
-18,000
| Closed | -$540K | – | 64 |
|
|
2017
Q2 | $540K | Sell |
18,000
-64,000
| -78% | -$1.92M | 0.59% | 26 |
|
|
2017
Q1 | $2.44M | Buy |
82,000
+18,000
| +28% | +$536K | 2.62% | 12 |
|
|
2016
Q4 | $2.21M | Buy |
+64,000
| New | +$2.21M | 1.58% | 17 |
|